Skip to search formSkip to main contentSkip to account menu

Cilastatin / Imipenem

Known as: imipenem-cilastatin, cilastatin, imipenem drug combination, imipenem - cilastatin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-lactamase Inhibitor, 1 Dosed in Combination with Imipenem/Cilastatin in… 
2016
2016
PreXDR and XDRTB (second line injectables SLI+/-fluoroquinolone FQ added to HR resistance) is a crucial Romanian issue since TB… 
2015
2015
The current study was conducted to observethe prevalence of different types of metallo -β-lactamases (MBLs) and their variants… 
2010
2010
Objective: To investigate the adverse drug reactions (ADRs) induced by imipenem-cilastatin and their relevant influence factors… 
2010
2010
PROBLEM/BACKGROUND: Imipenem+cilastatin is regarded as a broad-spectrum antibiotic exhibits time-dependent bactericidal activity… 
2005
2005
This study was performed to assess the incidence of infectious complications in patients undergoing autologous and allogeneic… 
1989
1989
Previously reported clinical trials of imipenem-cilastatin 500 mg given intravenously every 6 hours (intravenous group) and… 
1987
1987
The therapeutic effects of imipenem-cilastatin (MK-0787-MK-791) on experimental intrauterine infections in progesterone-treated… 
1986
1986
The single-dose pharmacokinetics of two dosages of imipenem-cilastatin (1:1), 10 and 25 mg/kg, were studied in ten children…